Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

Biological Technologies

Active
HR001126S0003Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is issuing a solicitation for proposals aimed at harnessing biological processes and properties to significantly enhance the protection and capabilities of the nation’s warfighters. This initiative seeks innovative approaches that go beyond incremental or evolutionary advancements to existing technologies, focusing instead on transformative breakthroughs that can revolutionize defense capabilities. The solicitation, titled "Biological Technologies," was posted on October 1, 2025, with a submission deadline of September 30, 2026. This opportunity is open under the Department of Defense’s DARPA BTO, without specific restrictions on organization types or set-asides, allowing broad participation from various sectors. While specific location requirements are not defined for the place of performance, interested parties can obtain further details or submit proposals by contacting the DARPA Biological Technologies Office via the provided email or phone number. The solicitation emphasizes creative and potentially disruptive biological research applications to fortify national defense and improve warfighter outcomes.

General Info

DARPA BTO seeks innovative biological technologies to transform and enhance warfighter protection capabilities.

Agency

Department Of Defense → Darpa - Biological Technologies OfficeView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

(14)

HR001126S0003 Cooperative Agreement V2

DOCX•cooperative-agreement

HR001126S0003 DARPA Streamlined Cost Proposal Spreadsheet V3

XLSX•cost-proposal-spreadsheet

HR001126S0003 DARPA Model Other Transaction Agreement for Prototype

DOCX•contract-document

HR001126S0003 Baseline Model Contract Addendum

DOCX•contract-document

HR001126S0003 Model Other Transaction Agreement for Research

DOCX•contract-document

HR001126S0003 Abstract Submission Template for Biological Technologies BAA

DOCX•abstract-template

Contract HR00112CXXX Accelerated Baseline Model Small Business

PDF•contract-document

DARPA BTO Broad Agency Announcement HR001126S0003 Biological Technologies

PDF•baa

HR001126S0003 Controlled Unclassified Information Guide

PDF•other

HR001126S0003 Attachment C Volume II Cost Proposal Instructions and Template

DOCX•cost-proposal-template

HR001126S0003 Biological Technologies Proposal Instructions and Volume I Template

DOCX•proposal-instructions-template

HR001126S0003 Classified Submission Instructions

DOCX•submission-instructions

Contract HR00112CXXX Award Document

PDF•contract-document

HR001126S0003 Attachment G Accelerated Award Option Election and Attestation Form

DOCX•attachment

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Darpa - Biological Technologies Office
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → Darpa - Biological Technologies Office
View Agency Profile
Office AddressUSA
Contacts
DARPA - Biological Technologies Office
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is soliciting proposals that leverage biological properties and processes to revolutionize our ability to protect the nation’s warfighters. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)
Solicitation # W911SR-26-R-HEAL
The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.
W6QK Acc-Apg

POSTED

1 day ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Federal
Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells
Solicitation # NIH-NOI-PCA-NIA-01590
The National Institute on Aging (NIA), under the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), has issued a Notice of Intent to Sole Source for the validation and optimization of ONE-STEP tagging in human induced pluripotent stem cells (iPSCs). This acquisition aims to support the iPSC Neurodegenerative Disease Initiative (iNDI) and the Center of Alzheimer’s Disease and Related Dementias (CARD) by generating functionally engineered iPSC lines for research into Alzheimer’s disease and related dementias. The project involves high-activity guide identification, Bxb1 mRNA and cargo plasmid delivery optimization, and the generation of ADRD variant, MAPT 4R, and wild-type process-control clones. All deliverables must be repository-ready, meeting strict quality control standards including long-read sequencing, karyotype analysis, and SNP arrays to ensure scientific continuity and data integrity. The government intends to award this contract to The Jackson Laboratory, citing them as the only responsible source capable of meeting the requirements under FAR 6.302-1 and FAR 13.501(a). This determination is based on the laboratory's unique continuity with the existing iNDI program, established workflows for specific background lines, and proven success in large-scale CRISPR/Cas9 engineering. The total estimated contract value is 3,353,115.00 dollars, covering a base year from September 1, 2026, to August 31, 2027, and an option year extending to August 31, 2028. While this is a sole-source intent, the government will consider capability statements from other sources submitted by August 21, 2026, to determine if adequate competition exists.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Federal
Sole Source - Production of ChAdOx-1 and MVA expressing mouse gp70
Solicitation # 75N98026Q00996
The National Cancer Institute intends to award a sole-source, firm fixed price contract under solicitation RFQ 75N98026Q00996 to the Viral Vector Core at the Pandemic Institute, University of Oxford. The project involves the design and production of ChAdOx-1 and MVA viral vectors expressing mouse gp70 and the mouse class II major histocompatibility complex invariant chain. This research is critical for evaluating vaccine efficacy against breast cancer brain metastasis, utilizing proprietary chimpanzee adenovirus technology to avoid pre-existing human adenovirus immunity. The contract falls under NAICS code 541714 for biotechnology research and development and has a performance period of six months from the date of award. Payment terms are set at net 30 days following the acceptance of deliverables. While intended as a sole-source procurement due to the proprietary nature of the technology, the agency will consider capability statements from other interested parties submitted by August 24, 2026.
NIH Nci

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 541714
New
Grant
Core Research in Biological Sciences (BIO Core)
Solicitation # 26-517
The National Science Foundation's Directorate for Biological Sciences is offering funding through the Core Research in Biological Sciences solicitation 26-517. This opportunity supports foundational and interdisciplinary research across all biological levels, from molecular to biome scales, encompassing both legacy program topics and new areas of biological science. The program provides single- and multi-investigator awards with flexible budgets and durations to accommodate both small exploratory projects and long-term research commitments. These federal awards are subject to the availability of funds and are managed by the National Science Foundation.
National Science Foundation

POSTED

2 days ago

DEADLINE

in almost 50 years
View Details
NAICS: 541714
New
Federal
On-Site Installation and Training ServicesThis subcontract opportunity with the Department of Commerce NIST involves on-site installation, calibration, and training services located in Gaithersburg, Maryland. The scope of work includes system setup and the verification of technical specifications. While these specific services are not mandatory, they will be given additional evaluation consideration if included in the proposal. The project is designated as a total Small Business Set Aside under NAICS code 541714. Interested parties must submit their responses by August 28, 2026, at 1:00 PM. The solicitation was officially posted on August 15, 2026.
Department Of Commerce Nist

POSTED

4 days ago

DEADLINE

in 9 days
View Details
NAICS: 541714
New
Federal
Q301--Zymo Epigenome Sequencing Services
Solicitation # 36C24126Q0748
The Department of Veterans Affairs, specifically the VA Bedford Healthcare System, intends to award a sole source, firm-fixed-price contract to Zymo Research Corporation for Reduced Representation Bisulfite Sequencing services. This project involves DNA methylation profiling of 269 post-mortem human choroid plexus tissue samples, encompassing sample handling, quality control, bisulfite conversion, library preparation, sequencing, and data alignment. The scope of work includes generating approximately 30 million read pairs per sample and producing genome browser tracks. This procurement is conducted as a sole source under authority RFO 6.103-1 because Zymo Research Corporation previously generated a prefrontal cortex dataset for the same study. Utilizing the same vendor is critical to avoid technical confounds that would compromise the scientific validity of the cross-tissue comparison. The requirement falls under NAICS code 541714 and PSC Q301. Interested parties must submit responses by August 21, 2026, at 11:00am EST.
241-NETWORK Contract Office 01 (36C241)

POSTED

5 days ago

DEADLINE

in 2 days
View Details
NAICS: 541714
New
Federal
Technical Readiness & Prototype DemonstrationThe Technical Readiness and Prototype Demonstration is a subcontract opportunity issued by the Department of Defense under the FA2553 Oprn Testing and Trg Infr Otti Pk agency. The primary objective of this effort is to demonstrate the technical capability to build, test, and deploy software from commercial facilities into government cloud enclaves, ensuring a secure and automated delivery process. This project falls under NAICS code 541714 and will be performed in Colorado Springs. Interested parties must submit their responses by September 4, 2026, following the posting date of August 13, 2026.
FA2553 Oprn Testing & Trg Infr Otti Pk

POSTED

6 days ago

DEADLINE

in 17 days
View Details
NAICS: 541714
New
Grant
Established Clinician Investigator Award to Support Mentoring (KS1)The Established Clinician Investigator Award to Support Mentoring (KS1) is a forecast opportunity issued by the National Institutes of Health under the Department of Health and Human Services. This award is designed to provide established clinician investigators with a sustained period of protected time, enabling them to deliver high-quality mentoring and guidance to early-career clinician research scientists. The program is managed by the Division of Biomedical Research Workforce, which serves as the primary point of contact for interested parties. While specific performance locations and set-aside details are not listed, the award aims to strengthen the pipeline of clinician researchers through structured mentorship support.
National Institutes Of Health

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
Grant
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)The National Institute on Aging is issuing a forecast for the Alzheimer's Drug-Development Program to support the pre-clinical and early-stage clinical Phase I development of novel biologic and small-molecule drug candidates. The program aims to identify treatments that prevent Alzheimer's disease, slow its progression, or address cognitive and behavioral symptoms. Funding is available for academic and biotech researchers to conduct development activities internally or through specialized contract research organizations. The initiative focuses on expanding the portfolio of investigational drug candidates for emerging therapeutic targets and diversifying the therapeutic pipeline to support mono-therapy, combination therapy, and precision medicine approaches. This opportunity will utilize the U01 activity code. While applications are not currently being accepted, this notice serves to allow potential applicants time to establish collaborations and design responsive projects.
National Institutes Of Health

POSTED

6 days ago

DEADLINE

N/A
View Details
NAICS: 541714
New
SLED
Online BAAS Hospitality Administration Degree Program Development
Solicitation # 754-TXST-2026-RFP-507-VPGOI
Texas State University is seeking a partner to develop a competitive and differentiated online Bachelor of Applied Arts and Science degree program in Hospitality Administration. The primary objective is to establish a high-quality academic offering where the total credit requirements are determined by the necessary standards to ensure the program remains distinct and competitive within the hospitality education market. This solicitation, identified by number 754-TXST-2026-RFP-507-VPGOI, was posted on August 12, 2026, with a response deadline of September 18, 2026. The project is managed by Texas State University in Texas, with Dan Alden serving as the primary point of contact for interested parties.
Texas State University

POSTED

6 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
SLED
Artificial Intelligence (AI) System Integration and GovernanceThis subcontract, titled Artificial Intelligence (AI) System Integration and Governance, is issued by the Texas Health and Human Services Commission. The project focuses on the integration of AI tools designed for administrative automation and case analysis. All implementations are strictly subject to ethical governance standards and require prior written approval from the Department of Family and Protective Services. The opportunity was posted on August 12, 2026, with a response deadline of September 3, 2026. It is categorized under NAICS code 541714, reflecting a focus on customized computer programming services. Interested parties can find further details through the Texas SmartBuy portal.
Health and Human Services Commission

POSTED

6 days ago

DEADLINE

in 16 days
View Details
NAICS: 541714
New
Federal
FDA-Cleared AI-Based Contouring IntegrationThe Department of Veterans Affairs, through Network Contract Office 16, is seeking a subcontract for the integration of AutoContour, an FDA-cleared AI system. This technology is designed to provide automated anatomical structure delineation to enhance radiation oncology treatment planning. The project will be performed in Jackson, Mississippi, under NAICS code 541714. Interested parties must submit their responses by August 21, 2026, at 3:00 PM. The solicitation was officially posted on August 12, 2026, and focuses on implementing advanced artificial intelligence to streamline clinical workflows within the VA healthcare system.
256-NETWORK Contract Office 16 (36C256)

POSTED

7 days ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Defense → Darpa - Biological Technologies Office

Same awarding agency

NAICS: 541611
Grant
Subcontract Management and ComplianceThe contract focuses on managing first-tier subcontracts in alignment with Federal Acquisition Regulation (FAR) clauses, ensuring adherence to small business participation goals and fulfilling federal reporting requirements. It is titled "Subcontract Management and Compliance" and is associated with the NAICS code 541611, which pertains to Administrative Management and General Management Consulting Services. The contract is issued by the Department of Defense’s Defense Advanced Research Projects Agency (DARPA), specifically under the Biological Technologies Office. The solicitation was posted on October 1, 2025, with a response deadline set for September 30, 2026. While specific details about the place of performance and point of contact are not provided, the contract is positioned to support DARPA’s mission by ensuring effective subcontract oversight, regulatory compliance, and fostering participation of small businesses in federally funded projects. The contract type is categorized under subcontracts, reflecting its role in managing downstream contractual relationships within government acquisition processes.
Administrative Management and General Management Consulting Services

POSTED

11 months ago

DEADLINE

in about 1 month
View Details
NAICS: 541211
Grant
Cost Proposal and Financial AdministrationThe contract involves the development and management of the cost volume in accordance with DARPA's specified templates, focusing on accurate indirect cost calculations and ensuring financial compliance throughout the process. It is designated as a subcontract under the Department of Defense’s Biological Technologies Office, with the NAICS code 541211, indicating a focus on engineering or related services. The contract requires adherence to detailed financial administration protocols to support DARPA's objectives efficiently. The solicitation was posted on October 1, 2025, and the response deadline is set for September 30, 2026, providing nearly a year for submission. While specific location details for performance and points of contact are not provided, the contract emphasizes strict compliance with DARPA financial requirements, suggesting a high level of accountability is expected from the contractor. The work supports DARPA’s mission by ensuring sound financial practices in the cost proposal phase, critical for project funding and oversight.
Offices of Certified Public Accountants

POSTED

11 months ago

DEADLINE

in about 1 month
View Details
NAICS: 541511
Grant
Software Development and Data DeliverablesThis contract involves the development, documentation, and delivery of software tools, algorithms, and data packages as part of research and development efforts. It is structured under cost-plus-fixed-fee (CPFF) terms, emphasizing collaboration and innovation in creating technical outputs. The work is intended to support the goals of the Department of Defense’s DARPA Biological Technologies Office, focusing on advanced software solutions related to biological research. The contract is a subcontract classified under NAICS code 541511, which pertains to custom computer programming services. Although specific location and contact details are not provided, the solicitation was posted on October 1, 2025, with a response deadline nearly a year later on September 30, 2026. The scope and deliverables focus on producing advanced R&D software and data packages, critical to furthering the objectives of this high-priority defense-related research initiative.
Custom Computer Programming Services

POSTED

11 months ago

DEADLINE

in about 1 month
View Details
NAICS: 541611
Grant
Technical Reporting and DocumentationThe contract involves the preparation and delivery of technical reports, summaries, and supporting documentation that must comply with government-mandated formatting standards and align with specified milestone requirements. This subcontract is associated with the Department of Defense's Darpa - Biological Technologies Office and falls under the NAICS code 541611, which pertains to administrative management and general management consulting services. The solicitation was posted on October 1, 2025, and the response deadline is set for September 30, 2026. While specific details about the place of performance and points of contact are not provided, the contract clearly emphasizes adherence to government guidelines for technical documentation to support ongoing government projects. This work is essential for maintaining transparency, ensuring accuracy, and meeting reporting obligations within government-funded research and development initiatives.
Administrative Management and General Management Consulting Services

POSTED

11 months ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
Grant
Research & Development Technical ExecutionThis contract involves conducting advanced biotechnology research and development under the oversight of the Defense Advanced Research Projects Agency (DARPA), specifically within its Biological Technologies Office. The scope includes experimental design, prototype development, and meeting milestone-driven deliverables, reflecting a structured and goal-oriented approach to technology innovation. It is categorized as a subcontract opportunity with a focus on NAICS code 541715, which covers research and development in the physical, engineering, and life sciences. The contract was posted on October 1, 2025, and has a response deadline of September 30, 2026, providing a near year-long window for interested parties to submit proposals. While specific details such as solicitation number, location, and point of contact are not provided, the work will be performed under the Department of Defense's Biological Technologies Office, indicating high-level federal research priorities with potential strategic implications. This opportunity is aimed at organizations capable of delivering cutting-edge biotech solutions within a disciplined, milestone-driven framework.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

11 months ago

DEADLINE

in about 1 month
View Details